3-Aminocyclobutanone hydrochloride
3-氨基环丁酮盐酸盐
Application
Abrocitinib
CAS No. 1035374-20-9
C₄H₈ClNO
Therapeutic Area
30 intermediates
Area Overview
Catalog programs in this area include JAK and TYK2 pathway modulators, immune-mediated dermatology candidates, inflammatory-disease programs and other targeted approaches to immune regulation.
Classification is based on terminal APIs in the product catalog; product counts update with the catalog.
Representative Terminal APIs
30 catalog intermediates
3-氨基环丁酮盐酸盐
Application
Abrocitinib
CAS No. 1035374-20-9
C₄H₈ClNO
3-氧代环丁烷甲酸
Application
Abrocitinib
CAS No. 23761-23-1
C₅H₆O₃
叔丁基(3-氧代环丁基)氨基甲酸酯
Application
Abrocitinib
CAS No. 154748-49-9
C₉H₁₅NO₃
2-(1-(乙基磺酰基)氮杂环丁-3-亚基)乙腈
Application
Baricitinib
CAS No. 1187595-85-2
C₇H₁₀N₂O₂S
1-(1-乙氧乙基)-4-(4,4,5,5-四甲基-1,3,2-二氧杂硼硼烷-2-基)-1H-吡唑
Application
Baricitinib / Ruxolitinib
CAS No. 1029716-44-6
C₁₃H₂₃BN₂O₃
4-氯-7-[2-(三甲基硅基)乙氧基]甲基-7H-吡咯并[2,3-d]嘧啶
Application
Baricitinib / Tofacitinib
CAS No. 941685-26-3
C₁₂H₁₈ClN₃OSi
1-Boc-5-氨基吲唑
Application
Belumosudil
CAS No. 129488-10-4
C₁₂H₁₅N₃O₂
2-溴-N-异丙基乙酰胺
Application
Belumosudil
CAS No. 75726-96-4
C₅H₁₀BrNO
N-异丙基-2-(3-(4-氧代-3,4-二氢喹唑啉-2-基)苯氧基)乙酰胺
Application
Belumosudil
CAS No. 2121561-39-3
C₁₉H₁₉N₃O₃
3-(4-氯-2-喹唑啉基)苯酚乙酸酯
Application
Belumosudil
CAS No. 911417-24-8
C₁₆H₁₁ClN₂O₂
布雷波替尼
Application
Brepocitinib
CAS No. 1883711-97-4
C₁₇H₁₅ClN₆O₂
氘可来昔替尼
Application
Deucravacitinib
CAS No. 1609392-27-9
C₂₀H₂₂N₈O₃
4 -氨基四氢吡喃-4-羧酸
Application
Lcotrokinra(JNJ-2113)
CAS No. 39124-20-4
C₆H₁₁NO₃
L-7-甲基色氨酸
Application
Lcotrokinra(JNJ-2113)
CAS No. 33468-36-9
C₁₂H₁₄N₂O₂
7-甲基吲哚
Application
Lcotrokinra(JNJ-2113)
CAS No. 933-67-5
C₉H₉N
N-苄氧羰基-L-谷氨酸-γ-叔丁酯
Application
Lcotrokinra(JNJ-2113)
CAS No. 3886-08-6
C₁₇H₂₃NO₆
N-芴甲氧羰基- 7-甲基-L-色氨酸
Application
Lcotrokinra(JNJ-2113)
CAS No. 1808268-53-2
C₂₇H₂₄N₂O₄
L-酪氨酸甲酯
Application
Lcotrokinra(JNJ-2113)
CAS No. 13512-31-7
C₁₈H₁₉NO₅
2-(三甲基硅基)乙氧基甲基氯
Application
Ruxolitinib
CAS No. 76513-69-4
C₆H₁₅ClOSi
3-环戊基丙烯腈
Application
Ruxolitinib
CAS No. 591769-05-0
C₈H₁₁N
吡唑-4-硼酸频哪酯
Application
Ruxolitinib
CAS No. 269410-08-4
C₉H₁₅BN₂O₂
(3R,4R)-1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐
Application
Tofacitinib
CAS No. 1062580-52-2
C₁₄H₂₄Cl₂N₂
1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐
Application
Tofacitinib
CAS No. 1228879-37-5
C₁₄H₂₄Cl₂N₂
4-氯-7-对甲苯磺酰基-7H-吡咯并[2,3-d]嘧啶
Application
Tofacitinib
CAS No. 479633-63-1
C₁₃H₁₀ClN₃O₂S
4-氯-7H-吡咯并[2,3-d]嘧啶
Application
Tofacitinib
CAS No. 3680-69-1
C₆H₄ClN₃
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-d]嘧啶-4-胺
Application
Tofacitinib
CAS No. 477600-74-1
C₁₃H₁₉N₅
(3R,4S)-3-(2-溴乙酰基)-4-乙基-1-吡咯烷甲酸苄酯
Application
Upadacitinib
CAS No. 1428243-26-8
C₁₆H₂₀BrNO₃
叔丁基5-对甲苯磺酰基-5H-吡咯并[2,3-b]吡嗪-2-基氨基甲酸酯
Application
Upadacitinib
CAS No. 1201187-44-1
C₁₈H₂₀N₄O₄S
(S)-4-(叔丁氧基羰基)-1,4-氧氮杂环庚烷-2-羧酸
Application
Brensocatib
CAS No. 1273567-44-4
C₁₁H₁₉NO₅
(S)-(1-氰基-2-(4-碘苯基)乙基)氨基甲酸
Application
Brensocatib
CAS No. 1159489-37-8
C₁₄H₁₇IN₂O₂
Need intermediates for this therapeutic area?
Ready to source? Our team responds to every inquiry within 24 hours.